Minute Insight: QuantumDX Launches Panel Test For Flu, COVID-19 And RSV
Medtech Insight spoke to the company’s CEO to find out what the announcement means for QPOC users, and how truly rapid point-of-care testing will aide triage.
You may also be interested in...
QuantumDX Inks Deal To Distribute IVD Tests In China
The CEO of QuantumDX, Jonathan O’Halloran, spoke to Medtech Insight about the benefits of selling diagnostics in China and argued for a pragmatic approach to IP protection when launching in a country where counterfeiting is common.
MDR And IVDR – Similar Step Ups, Varying Commercial Impacts
Medtech Insight spoke to the CEOs of two companies that recently had very different experiences with the new European IVDR and MDR regulations to gauge their thoughts on any potential commercial impacts.
The Illumina Shareholder Votes Are In, And Nobody Got What They Wanted
Carl Icahn was successful in ousting Illumina’s chair, however its CEO, Francis deSouza remains. Both analysts and investors believe this could further encourage Illumina to divest Grail.